NutraIngredients NutraTalk Podcast

Opening up the innovation process to outside expertise is increaingly seen as a way to advance and cut costs.

Inneov, the joint venture between Nestle and L’Oreal to develop beauty supplements, says regulatory clarity is needed in the area of beauty claims on non-topical beauty applications that in many cases fall between cosmetics and food law.

Shane Starling met with Patrick Coppens, the secretary general of the European Responsible Nutrition Alliance (ERNA), after the European Food Safety Authority’s (EFSA) article 13.5 and 14 health claim stakeholders meeting on Monday in Brussels.

The long-awaited meeting between the European Food Safety Authority (EFSA) and industry was 'fruitful', said industry representatives, and follows promises from EFSA for greater transparency and thoroughness in its health claim opinions.

Shane Starling reports from the European Food Safety Authority’s (EFSA) much anticipated industry stakeholders’ meeting about health claims in Brussels today.

Vitamin E tocotrienols are dwarves in a land of tocopherols – the vitamin E giants. But the tocotrienol market is growing. Stephen Daniells talks to Lipid Nutrition’s John Kurstjens, and Carotech’s Sharon Ling, about entry to the market, the benefits of competition, and new areas for tocotrienol science.

Vitamin E tocotrienols are slowing coming out of the shadow of tocopherols. Stephen Daniells talks to Dr Barrie Tan from American River Nutrition, about new sources of tocotrienols, new entrants to the market, and where the health benefits lie.

Vitamin K has been linked to bone, heart, and even prostate health, but could joint health and cartilage be next on the horizon for the unKnown vitamin? Stephen Daniells talks to Prof Cees Vermeer from VitaK, about raising awareness on vitamin K, dietary intakes, and new applications.

Chief operating officer at Glanbia Nutritionals Dr Raimund Hoenes sat down with Shane Starling at Vitafoods in Geneva and shared insights into some of the challenges the sub-division of the Irish dairy giant has faced since its inception two years ago with a brief to develop an infant and sports nutrition ingredients portfolio.

Are health claims dossiers really that expensive, and has the ‘wait and see’ approach to submitting dossiers won? Stephen Daniells speaks to Joerg Gruenwald, PhD, President of Analyze & Realize, about how much it costs to compile a dossier, and why it’s better to wait than rush a health claims proposal.